dr. byrd on ibrutinib's impact on treatment landscape in cll
Published 8 years ago • 704 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
1:20
dr. byrd provides an update on ibrutinib in cll
-
0:39
dr. byrd on ibrutinib in cll
-
0:57
dr. byrd on alacabrutinib's mechanism of action in cll
-
0:51
dr. byrd on impact of ibrutinib on patients with cll
-
2:28
dr. john byrd on ibrutinib in cll
-
1:09
dr. byrd on long-term safety data with ibrutinib in cll
-
1:06
dr. john byrd discusses the treatment landscape for cll
-
1:06
dr. byrd on combination strategies in cll
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
10:22
the changing treatment landscape in cll
-
7:13
using ibrutinib in chronic lymphocytic leukemia (cll)
-
1:16
dr. wierda on ibrutinib plus venetoclax in cll
-
4:02
managing ibrutinib toxicity in cll
-
0:51
dr. seymour on role of ibrutinib in cll
-
0:48
dr. byrd on bruton's tyrosine kinase in chronic lymphocytic leukemia
-
1:29
dr. james on update of ibrutinib for chronic lymphocytic leukemia
-
1:34
dr. byrd on updated resonate findings in cll
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
1:36
dr. john byrd on challenges in cll